Search

everythinglearnresearchcommunity

for

Search:↓

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Visceral leishmaniasis can mimic rheumatoid arthritis symptoms, especially in immunocompromised patients.

A 70-year-old woman with bronchiectasis developed a rare immune disease due to a bacterial infection, requiring a difficult balance of treatments.

Azathioprine caused side effects in over half of the Korean pediatric inflammatory bowel disease patients, requiring close monitoring.

A kidney transplant patient on cyclosporin experienced unexpected severe hair loss, which improved with treatment adjustments.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Contact immunotherapy helped hair regrow in a patient with both alopecia and psoriasis.

The study suggests that a specific type of immune cell, memory-like NK cells, may increase during active hair loss in Alopecia areata.

Oral cyclosporine A and prednisolone effectively improved alopecia universalis without side effects.

A girl with Crohn's disease developed hair loss from her medication, which improved with treatment but later returned.

Renal transplant patients on tacrolimus and sirolimus may develop acne keloidalis nuchae.

A 16-year-old girl with lupus symptoms improved with treatment despite negative ANA tests.

The NUDT15 gene variant causes severe side effects from azathioprine in some Indian patients.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

Dermatologists are hesitant to prescribe Janus kinase inhibitors for alopecia areata due to safety concerns and lack of knowledge.

The treatment was effective for lupus nephritis with manageable side effects.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Hairless mice are more vulnerable to Listeria infection, but gut microbiota can help reduce damage.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

A cancer patient's hair became permanently curly after treatment with nivolumab.

Accurate fungal identification is crucial for proper treatment in immunocompromised patients.

Baricitinib is a safe and effective treatment for alopecia areata, with better results in patients with lower initial severity, shorter disease duration, and longer treatment.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

Younger patients and those with more hair loss are less likely to benefit from oral steroid treatment for hair loss, and low vitamin D may predict relapse.

Dermatologists should guide patients on blood donation timing due to various eligibility criteria.

Single-cell engineered biotherapeutics show promise for skin treatment but need more research and trials.